8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
IDEXX reports 10% Q2 revenue growth and raises 2026 EPS outlook
Filed with the SEC on · Summarized by InvestorsBot
IDEXX reported second-quarter 2026 revenue of $1.217 billion for the period ended June 30, up 10% year over year, while diluted EPS rose 18% to $4.27; CAG Diagnostics recurring revenue increased 11% as reported. The company raised its 2026 EPS outlook to $14.69-$14.94 and narrowed revenue guidance to $4.700-$4.745 billion, despite a projected $15 million foreign-exchange headwind.